Background Over the last two decades, antidepressant prescribing in the UK has increased considerably, due to an increased number of people staying on antidepressants for longer. Even when treatment is no longer clinically indicated, qualitative research suggests many people continue due to a fear of depressive relapse or antidepressant withdrawal symptoms. The quantitative effects of peoples’ beliefs and attitudes towards long-term antidepressant use remain relatively unexplored.

Objectives To determine the extent to which beliefs and attitudes towards antidepressant treatment predict intentions to stop or continue long-term use; and whether intentions translate into actual discontinuation.

Methods A questionnaire survey formed the main component of an embedded mixed-methods study. Twenty general practices posted questionnaires to adults aged over 18 receiving continuous antidepressant prescriptions for over two years. Outcomes and predictors were determined using an extended model of the Theory of Planned Behaviour, conducting exploratory descriptive and regression analyses. The primary outcome was participants’ intentions to discontinue antidepressants. The secondary outcome of behaviour change was determined by any change in antidepressant dosage at six months.

Results 277 people were surveyed from 20 practices, with 10 years median antidepressant duration. Mean questionnaire scores for intention and subjective norms towards starting to come off antidepressants were low, and 85% of participants declared that continuing their antidepressant was necessary. Prescribing outcomes retrieved from 175 participants’ medical records six months after they completed the survey found 86% had not changed their antidepressant, 9% reduced the dose, only 1% discontinued their antidepressant, and 4% increased the dose. More favourable attitudes towards stopping, and normative beliefs about depression, were the strongest predictors of intentions to stop long-term antidepressant treatment.

Conclusion Given few intentions to stop taking antidepressants, patients should be made more aware of the importance of ongoing antidepressant monitoring and review from their primary care practitioners. This would promote discussion to support an attitudinal change and initiation of antidepressant tapering where appropriate.

I have read the journal's policy and the authors of this manuscript have the following competing interests: TK, AWG and BS have received grant funding from the NIHR Research for Patient Benefit programme to conduct research into helping people come off inappropriate long-term antidepressants.

Yes

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was ethically approved through proportionate review by Yorkshire & The Humber – Leeds East Research Ethics Committee (REC ID: 17/YH/0223). Completion of the questionnaire indicated implied consent. Participants were required to provide written consent for their GP practice to provide medical notes data.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

The Ethical Approvals provided by the Sponsor (University of Southampton), NHS Research Ethics Committee, and Health Research Authority, states that “Access to raw data and right to publish freely by all investigators in study or by Independent Steering Committee on behalf of all investigators” will not form part of the dissemination plan. Furthermore, participants have not provided consent for the data to be shared anonymously for other ethically approved research in the future.